ProPhase Labs
Ted Karkus is the current CEO and Chairman of ProPhase Labs, where he oversees corporate strategy, product development, sales and marketing, and R&D. Prior to that, he founded and served as President of Forrester Financial, LLC/Prophase Mgmt, Inc., providing management consulting services to small, emerging-growth companies. Before that, he was the Director of Institutional Equities/Senior Vice President at Fahnestock & Co. Inc., and Vice President/Senior Institutional Equity Salesman at S.G. Warburg & Co. Ted holds an MBA in Finance and Economics from Columbia Business School and a BS in Psychology from Tufts University.
ProPhase Labs
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Our world-class CLIA labs and cutting-edge diagnostic technology provide wellness solutions for healthcare providers and consumers. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach.